Spravato and Bipolar Depression
Bipolar depression can be challenging to treat. At Next Step Psychiatry, we understand the complexities of mood disorders.
Current FDA Approval Status
Spravato is currently FDA-approved for:
- Treatment-resistant unipolar depression
- Major depressive disorder with suicidal ideation
Important: Spravato is NOT FDA-approved specifically for bipolar depression.
What the Research Shows
Emerging research on ketamine/esketamine for bipolar depression is promising:
- Some studies show rapid antidepressant effects
- Careful monitoring is essential
- Risk of triggering mania must be considered
Treatment Approach at Next Step Psychiatry
Our experienced providers at Next Step Psychiatry:
- Carefully evaluate each case
- Consider all treatment options
- Monitor closely for mood switches
- Coordinate comprehensive care
Comprehensive Bipolar Care
We offer multiple treatment approaches for bipolar disorder:
- Mood stabilizers
- Antipsychotic medications
- Therapy coordination
- Advanced treatments when appropriate
Schedule a Consultation
Contact us at (678) 437-1659 to discuss your options. Check your insurance coverage at Next Step Psychiatry.
Related Topics
spravato bipolaresketamine bipolar depressionbipolar treatment atlantabipolar resistant depression
Ready to Explore Spravato Treatment?
If you're struggling with treatment-resistant depression, Spravato could be the breakthrough you've been waiting for. Contact Next Step Psychiatry in Atlanta for a consultation.